PMMR
Clinical trials for PMMR explained in plain language.
Never miss a new study
Get alerted when new PMMR trials appear
Sign up with your email to follow new studies for PMMR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple threat: radiotherapy, chemo, and immunotherapy take on spread rectal cancer
Disease control Recruiting nowThis phase 2 trial is testing a new approach for people with a specific type of rectal cancer that has spread to a few other spots in the body (oligometastases). The treatment combines short-course radiotherapy, chemotherapy (CAPEOX), and an immunotherapy drug called serplulimab …
Matched conditions: PMMR
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New cocktail aims to shrink rectal tumors before surgery
Disease control Recruiting nowThis study is for people with a certain type of locally advanced rectal cancer (pMMR/MSS) that often doesn't respond well to immunotherapy alone. The trial combines an immunotherapy drug (serplulimab) with chemotherapy (CAPEOX) and an anti-inflammatory drug (celecoxib) to see if …
Matched conditions: PMMR
Phase: PHASE2 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC